相关实验视频

Updated: Jul 23, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

在前列腺癌中,SCARA5过度表达,并与预后不佳有关

Fidelis Andrea Flockerzi¹, Johannes Hohneck¹, Matthias Saar^2,3

¹Department of Pathology, Saarland University Medical Center, 66424 Homburg, Germany.

Diagnostics (Basel, Switzerland)

|July 14, 2023

概括

拾取器受体A类成员5 (SCARA5) 是前列腺癌中的潜在生物标志物. 高SCARA5表达与晚期瘤阶段,结节状况和格里森得分相关,这表明它在癌症进展中的作用.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物标志物发现发现

背景情况:

前列腺癌表现出不同的临床行为,需要新的预后和预测标记.
以前的研究将THSD7A的表达与前列腺癌的预后不良因素联系起来.
SCARA5是THSD7A的下游基因,与各种癌症有关,通常作为瘤抑制剂,并可能与焦粘附激酶 (FAK) 相互作用.

研究的目的:

研究SCARA5作为前列腺癌潜在生物标志物的作用.
分析SCARA5表达与已确定的预后参数之间的关联.
为了比较SCARA5表达与前列腺癌组织中的THSD7A和FAK水平.

主要方法:

对SCARA5表达的免疫组织化学分析.
利用来自461例前列腺癌病例的组织微阵列.
与瘤阶段,结节状况,格里森得分,THSD7A和FAK表达相关的SCARA5表达.

主要成果:

高SCARA5表达与晚期瘤阶段显著相关 (p < 0.001).
阳性结节状况 (p < 0.001) 和高格里森得分 (p < 0.001) 与SCARA5水平升高有关.
强大的SCARA5阳性与THSD7A阳性相关,但没有发现与FAK表达有显著的关联.

结论:

在前列腺癌中,SCARA5可能是潜在的预后生物标志物.
这项研究是首次探索SCARA5在前列腺癌中的作用.
SCARA5与不良预后因素的关联需要进一步调查.

关键词:

这就是SCARA5的 SCARA5.这就是THSD7A.前列腺癌是前列腺癌.

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...